TELA Bio (TELA) Research & Development (2018 - 2026)

TELA Bio's Research & Development history runs 9 years deep, the most recent figure standing at $16.5 million for Q1 2026.

• On a quarterly basis, Research & Development changed 0.43% year-over-year to $16.5 million in Q1 2026; TTM through Mar 2026 was $104.7 million, a 199.55% increase from a year earlier, with the FY2025 full-year figure at $63.2 million, down 2.27% from the prior year.
• Research & Development declined to $16.5 million in Q1 2026 per TELA's latest filing, from $56.1 million in the prior quarter.
• Across five years, Research & Development topped out at $56.1 million in Q4 2025 and bottomed at $2.0 million in Q1 2022.
• The 5-year median for Research & Development is $11.6 million (2022), against an average of $12.1 million.
• Across the five-year window, Research & Development plunged 85.71% in 2024 and soared 636.32% in 2025, its largest moves.
• Year by year, Research & Development stood at $11.6 million in 2022, then surged by 47.37% to $17.2 million in 2023, then decreased by 18.68% to $14.0 million in 2024, then jumped by 301.88% to $56.1 million in 2025, then plunged by 70.52% to $16.5 million in 2026.
• Per Business Quant, the three latest TELA Research & Development figures stand at $16.5 million (Q1 2026), $56.1 million (Q4 2025), and $15.2 million (Q3 2025).